Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema

AbstractCombined pulmonary fibrosis and emphysema (CPFE) is defined as upper lobe emphysema and lower lobe fibrosis, which are representative lung disorders that increase the prevalence of lung cancer. This unique disorder may affect the morbidity and mortality during the early period after surgery. The present study aimed to identify which clinicopathological features significantly affect early surgical outcomes after lung resection in nonsmall cell lung cancer (NSCLC) patients and in those with CPFE.We retrospectively assessed 2295 patients with NSCLC and found that 151 (6.6%) had CPFE. All were surgically treated between January 2008 and December 2010 at 4 institutions.The postoperative complication rates for patients with and without CPFE were 39% and 17%, respectively. The 90-day mortality rates were higher among patients with than without CPFE (7.9% vs 1%). Acute exacerbation of interstitial pneumonia was the main cause of death among 12 patients with CPFE who died within 90 days after surgery. Multivariate logistic regression analysis selected CPFE, gender, age, and clinical stage as independent predictive factors for postoperative complications, and CPFE, clinical stage, and sex for 90-day mortality. The severity of lung fibrosis on preoperative CT images was an independent predictive factor for 90-day mortality among patients with CPFE.The key predictive factor for postoperative mortality and complications of lung resection for NSCLC was CPFE. The severity of lung fibrosis was the principal predictor of early outcomes after lung surgery among patients with CPFE and NSCLC.

[1]  M. Okada,et al.  Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes. , 2015, Japanese journal of clinical oncology.

[2]  M. Okada,et al.  What are the radiologic findings predictive of indolent lung adenocarcinoma? , 2015, Japanese journal of clinical oncology.

[3]  PhD Takahiro Mimae MD,et al.  Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema , 2015, Annals of Surgical Oncology.

[4]  Kenji Suzuki,et al.  Distribution of interstitial pneumonia: a new radiological predictor of 90-day mortality after resection of lung cancer , 2015, Surgery Today.

[5]  Y. Doki,et al.  Thoracic and cardiovascular surgery in Japan during 2012 , 2014, General Thoracic and Cardiovascular Surgery.

[6]  H. Middlekauff,et al.  Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. , 2014, Journal of the American College of Cardiology.

[7]  Y. Takeshima,et al.  Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma. , 2014, The Journal of thoracic and cardiovascular surgery.

[8]  A. Kotanidou,et al.  The Role of Cardiopulmonary Exercise Test in IPF Prognosis , 2013, Pulmonary medicine.

[9]  M. Okada,et al.  Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema , 2013, Thorax.

[10]  H. Kuwano,et al.  Thoracic and cardiovascular surgery in Japan during 2011 , 2013, General Thoracic and Cardiovascular Surgery.

[11]  V. Cottin The impact of emphysema in pulmonary fibrosis , 2013, European Respiratory Review.

[12]  Michael J Thun,et al.  50-year trends in smoking-related mortality in the United States. , 2013, The New England journal of medicine.

[13]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[14]  T. Higami,et al.  Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis , 2013, General Thoracic and Cardiovascular Surgery.

[15]  Hiroki Takahashi,et al.  Clinical Characteristics Of Combined Pulmonary Fibrosis And Emphysema , 2012, ATS 2012.

[16]  S. Rounds,et al.  Combined pulmonary fibrosis and emphysema syndrome: a review. , 2012, Chest.

[17]  Y. Kawabata,et al.  Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. , 2011, The Annals of thoracic surgery.

[18]  T. Honda,et al.  Clinical characteristics of combined pulmonary fibrosis and emphysema , 2010, Respirology.

[19]  P. Metcalf,et al.  COPD prevalence is increased in lung cancer, independent of age, sex and smoking history , 2009, European Respiratory Journal.

[20]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  J. Tschopp,et al.  Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. , 2006, The Annals of thoracic surgery.

[22]  E. Venkatraman,et al.  Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. , 2006, Chest.

[23]  V. Cottin,et al.  Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. , 2005, American journal of respiratory and critical care medicine.

[24]  P. Brillet,et al.  Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.

[25]  J. Ambrose,et al.  The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.

[26]  K. Yasuda,et al.  Thoracic and cardiovascular surgery in Japan during 2001: annual report by the Japanese Association for Thoracic Surgery. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[27]  H. Collard,et al.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[28]  K. Yasuda,et al.  Thoracic and Cardiovascular Surgery in Japan during 2000 : Annual Report by The Japanese Association for Thoracic Surgery , 2002 .

[29]  Y. Nishiwaki,et al.  Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis , 2002, Journal of surgical oncology.

[30]  Kenji Suzuki,et al.  Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis , 2001, Journal of surgical oncology.

[31]  R. Hubbard,et al.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.

[32]  M. Shulman,et al.  Preoperative pulmonary evaluation. , 1999 .

[33]  M. Muers,et al.  The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. , 1995, Respiratory medicine.

[34]  J. Clarke,et al.  Medicine , 1907, Bristol medico-chirurgical journal.